Researchers were awarded approximately $3 million from the National Institutes of Health to continue studying how our bodies respond to seasonal and pandemic flu viruses and vaccines.
Rochester researchers found that a high dose of a common antidepressant drug (citalopram) significantly reduced agitation in Alzheimer’s patients. Agitation is one of the most common reasons Alzheimer’s patients are moved out of their homes into higher levels of care.
A Phase 2 clinical trial of the nutritional supplement inosine has shown that the compound can safely and effectively raise levels of urate, a naturally occurring compound found in blood. Scientists suspect that urate may slow the progression of Parkinson’s disease.
With incredibly rare diseases like Juvenile Batten Disease, the road map for moving research from the lab to patients is often unclear. This week, researchers, parents and representatives of advocacy groups from across the United States and Europe convene at the Medical Center to discuss the future of clinical trials for this devastating disorder.
In a recent study in Nature Immunology, Deborah Fowell, Ph.D., associate professor of Microbiology and Immunology, mapped how immune cells travel to sites of injury or infection. She says the findings could help with the development of treatments that stop, slow down or speed up the immune response. Check out this video of Fowell for more details on her work.
Cardiologists at the University of Rochester Medical Center are launching a new study in an effort to improve the treatment of a very common form of heart disease in the Asian population.
The goal of this blog is to bring more medical research stories to light and provide our readers with timely and engaging coverage of scientific and medical developments here in Rochester and beyond.
April 2014 (4)
March 2014 (8)
February 2014 (11)
January 2014 (6)
December 2013 (10)
November 2013 (5)
October 2013 (8)
September 2013 (7)
August 2013 (12)
July 2013 (12)
June 2013 (14)
May 2013 (2)